Regulation of pigmentation in human epidermal melanocytes by functional high-affinity beta-melanocyte-stimulating hormone/melanocortin-4 receptor signaling.

To date, the principal receptor considered to regulate human pigmentation is the melanocortin-1 receptor (MC1-R) via induction of the cAMP/protein kinase A pathway by the melanocortins alpha-MSH and ACTH. In this context, it is noteworthy that beta-MSH can also induce melanogenesis, although it has a low affinity for the MC1-R, whereas the preferred receptor for this melanocortin is the MC4-R. Because beta-MSH is present in the epidermal compartment, it was of interest to ascertain whether functioning MC4-Rs are present in human epidermal keratinocytes and melanocytes. Our results provide evidence that the MC4-R is expressed in situ and in vitro throughout the human epidermis at the mRNA and protein level using RT-PCR, Western blotting, and double immunofluorescence staining. Moreover, radioligand binding studies yielded high-affinity receptors for beta-MSH on epidermal melanocytes (3600 receptors per cell), undifferentiated keratinocytes (7200 receptors per cell), and differentiated keratinocytes (72,700 receptors per cell), indicating that MC4-R expression correlates with epidermal differentiation. Importantly, increased melanogenesis after stimulation of the beta-MSH/cAMP/microphthalmia-associated transcription factor/tyrosinase cascade proved the functionality of this signal in melanocytes, which was attenuated in the presence of the specific MC4-R antagonist HS014. In summary, our results imply an important role for the beta-MSH/MC4-R cascade in human melanocyte biology, although the function and purpose of this signal in keratinocytes needs further elucidation.

[1]  N. J. Gibbons,et al.  The Ca2+-binding capacity of epidermal furin is disrupted by H2O2-mediated oxidation in vitiligo. , 2008, Endocrinology.

[2]  S. Kõks,et al.  Gene expression analysis of melanocortin system in vitiligo. , 2007, Journal of dermatological science.

[3]  H. Schiöth,et al.  Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes. , 2007, Endocrinology.

[4]  G. Baldini,et al.  Constitutive Traffic of Melanocortin-4 Receptor in Neuro2A Cells and Immortalized Hypothalamic Neurons* , 2007, Journal of Biological Chemistry.

[5]  T. Gudermann,et al.  The Natural Inverse Agonist Agouti-related Protein Induces Arrestin-mediated Endocytosis of Melanocortin-3 and -4 Receptors* , 2006, Journal of Biological Chemistry.

[6]  A. Bitto,et al.  Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. , 2006, Endocrinology.

[7]  H. Rokos,et al.  A novel mechanism in control of human pigmentation by {beta}-melanocyte-stimulating hormone and 7-tetrahydrobiopterin. , 2005, The Journal of endocrinology.

[8]  T. Luger,et al.  Melanocortins in fibroblast biology – current update and future perspective for dermatology , 2004, Experimental dermatology.

[9]  D. Tobin,et al.  Melanin pigmentation in mammalian skin and its hormonal regulation. , 2004, Physiological reviews.

[10]  H. Schiöth,et al.  Roles of the melanocortin-4 receptor in antipyretic and hyperthermic actions of centrally administered α-MSH , 2004, Brain Research.

[11]  P. Delagrange,et al.  Agouti-related protein antagonizes glucocorticoid production induced through melanocortin 4 receptor activation in bovine adrenal cells: a possible autocrine control. , 2004, Endocrinology.

[12]  D. Tobin,et al.  Regulation of Human Epidermal Melanocyte Biology By β-Endorphin , 2003 .

[13]  P. Widdowson,et al.  β-MSH: a functional ligand that regulated energy homeostasis via hypothalamic MC4-R? , 2003, Peptides.

[14]  A. Rehemtulla,et al.  Proprotein convertase expression and localization in epidermis: evidence for multiple roles and substrates , 2001, Experimental dermatology.

[15]  Z. Abdel‐Malek.  Melanocortin receptors: their functions and regulation by physiological agonists and antagonists , 2001, Cellular and Molecular Life Sciences CMLS.

[16]  A. Slominski,et al.  Neuroendocrinology of the skin. , 2000, Endocrine reviews.

[17]  R. Paus,et al.  Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. , 2000, Physiological reviews.

[18]  G. Barsh,et al.  The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. , 2000, Pigment cell research.

[19]  N. Seidah,et al.  Pro-opiomelanocortin-related peptides, prohormone convertases 1 and 2 and the regulatory peptide 7B2 are present in melanosomes of human melanocytes. , 2000, The Journal of investigative dermatology.

[20]  K. Wakamatsu,et al.  Skin POMC Peptides: Their Binding Affinities and Activation of the Human MC1 Receptor , 1999, Annals of the New York Academy of Sciences.

[21]  Roger D. Cone.  Le système de la mélanocortine centrale et son rôle dans l'homéostase énergétique , 1999 .

[22]  A. Slominski,et al.  Animals under the sun: effects of ultraviolet radiation on mammalian skin. , 1998, Clinics in dermatology.

[23]  P. Prusis,et al.  Discovery of novel melanocortin4 receptor selective MSH analogues , 1998, British journal of pharmacology.

[24]  W. Wilkison,et al.  Linkage and Association Studies between the Melanocortin Receptors 4 and 5 Genes and Obesity-Related Phenotypes in the Québec Family Study , 1997, Molecular medicine.

[25]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[26]  J. B. Tatro.  Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. , 1996, Neuroimmunomodulation.

[27]  J. Wikberg,et al.  Characterisation of the melanocortin 4 receptor by radioligand binding. , 1996, Pharmacology & toxicology.

[28]  J. Wikberg,et al.  Major pharmacological distinction of the ACTH receptor from other melanocortin receptors. , 1996, Life sciences.

[29]  V. Chhajlani,et al.  Distribution of cDNA for melanocortin receptor subtypes in human tissues. , 1996, Biochemistry and molecular biology international.

[30]  Richard P. Woychik,et al.  Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor , 1994, Nature.

[31]  J. Mazurkiewicz,et al.  Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. , 1993, The Journal of laboratory and clinical medicine.

[32]  A. Chakraborty,et al.  MSH receptors in immortalized human epidermal keratinocytes: A potential mechanism for coordinate regulation of the epidermal‐melanin unit , 1993, Journal of cellular physiology.

[33]  A. Chakraborty,et al.  The effect of tryptophan on dopa-oxidation by melanosomal tyrosinase. , 1993, The International journal of biochemistry.

[34]  A. Lerner.  The Discovery of the Melanotropins: A History of Pituitary Endocrinology a , 1993, Annals of the New York Academy of Sciences.

[35]  A. Chakraborty,et al.  Up-regulation of MSH receptors by MSH in Cloudman melanoma cells. , 1992, Biochemical and biophysical research communications.

[36]  K. Rosenzweig,et al.  Molecular cascades in UV-induced melanogenesis: a central role for melanotropins? , 1992, Pigment cell research.

[37]  S. Orlow,et al.  Structural/functional relationships between internal and external MSH receptors: Modulation of expression in Cloudman melanoma cells by UVB radiation , 1991, Journal of cellular physiology.

[38]  J. Pawelek,et al.  UVB-induced melanogenesis may be mediated through the MSH-receptor system. , 1989, The Journal of investigative dermatology.

[39]  V. Hearing,et al.  Expression of melanocyte stimulating hormone receptors correlates with mammalian pigmentation, and can be modulated by interferons , 1988, Journal of cellular physiology.

[40]  J. Pawelek,et al.  Receptors for B-melanocyte-stimulating hormone exhibit positive cooperativity in synchronized melanoma cells. , 1988, Biochemistry.

[41]  J. Pawelek,et al.  Phosphorylated isomers of L-dopa stimulate MSH binding capacity and responsiveness to MSH in cultured melanoma cells. , 1987, Biochemical and biophysical research communications.

[42]  J. Pawelek,et al.  Studies on the Cloudman melanoma cell line as a model for the action of MSH. , 1985, The Yale journal of biology and medicine.

[43]  P. Elias,et al.  Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry. , 1985, The Journal of investigative dermatology.

[44]  A. Lerner,et al.  Iodination of beta-melanotropin. Time course analysis of reaction mixtures by high pressure liquid chromatography and characterization of biologically active mono- and diiodo-beta-melanotropin. , 1982, The Journal of biological chemistry.

[45]  T. Fitzpatrick,et al.  The evolution of concepts of melanin biology. , 1967, Archives of dermatology.

[46]  A. Lerner,et al.  Effect of Alpha- and Beta-Melanocyte Stimulating Hormones on the Skin Colour of Man , 1961, Nature.

[47]  J. Lunec,et al.  The expression of functional MSH receptors on cultured human melanocytes , 2004, Archives of Dermatological Research.

[48]  H. Schiöth.  The physiological role of melanocortin receptors. , 2001, Vitamins and hormones.

[49]  A. Slominski,et al.  A possible role for melanin precursors in regulating both pigmentation and proliferation of melanocytes. , 1988, Progress in clinical and biological research.

[50]  J. Gerst,et al.  Dual regulation of beta-melanotropin receptor function and adenylate cyclase by calcium and guanosine nucleotides in the M2R melanoma cell line. , 1987, Molecular pharmacology.